Skip to content

Pilot Study of Strepic® Device for the Diagnosis of Group A Streptococcal Pharyngitis

Pilot Study of Strepic® Device for the Diagnosis of Group A Streptococcal Pharyngitis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03777098
Enrollment
426
Registered
2018-12-17
Start date
2019-01-02
Completion date
2021-12-30
Last updated
2022-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Group A Streptococcal Infection

Brief summary

The objective of this pilot study is to acquire images using the Strepic® device, a clinical prototype that has been designed specifically as a viable, low-cost, commercially realizable autofluorescence-based diagnostic test, using (1) fluorescence and (2) white light image data, as well as other clinical data points. By acquiring and analyzing the images of pharyngeal bacterial fluorescence and white light patterns in patients with Group A Streptococcus (GAS)-associated pharyngitis and comparing them with those observed in non-GAS pharyngitis, it is believed an algorithm can be developed such that the device will improve the ability of clinicians to quickly and accurately identify GAS infections.

Interventions

DEVICEStrepic® Device

The Strepic® device is a qualitative point-of-care diagnostic test for the detection of GAS pharyngitis. The test uses direct visualization of the pharynx with a light source of specified wavelengths, causing excitation of endogenous fluorophores that emit a characteristic colored light pattern. White light images may give additional diagnostic accuracy through use of an artificial intelligence analysis of a large set of images of GAS and non-GAS pharyngitis.

Sponsors

Light AI, Inc.
CollaboratorUNKNOWN
David A. Talan
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
7 Years to 64 Years
Healthy volunteers
No

Inclusion criteria

1. All patients aged 7-64 years of age with suspected GAS pharyngitis with modified Centor (McIsaac) score ≥2; and 2. Patient agrees to participate in study and patient or parent/guardian sign consent/assent form.

Exclusion criteria

1. Pharyngeal swab performed immediately prior to study team approach; 2. Prior enrollment in this study; 3. Pharyngeal symptoms \>7 days; 4. Peritonsillar abscess; 5. Antibiotic use within one week of index visit; 6. Inability to open mouth to visualize the pharynx; and 7. Inability to understand English or Spanish, as study forms including consent and assent forms will be written in English and Spanish; 8. Woman who is pregnant (self-reported, pregnancy test will not be performed) or nursing; 9. Current prisoner (define as an individual involuntarily confined in a penal institution, including persons: (1) sentenced under a criminal or civil statue; (2) detained pending arraignment, trial, or sentencing; and (3) detained in other facilities (e.g., for drug detoxification or treatment of alcoholism) under statutes or commitment procedures providing such alternatives to criminal prosecution or incarceration in a penal institution).

Design outcomes

Primary

MeasureTime frameDescription
Strepic Device ImageDay 1A picture of the participant's throat will be obtained at enrollment.
Throat culture or PCR resultDay 2The results of throat culture or PCR (depending on the site) will be recorded and compared to the Strepic Device image findings

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026